Inventor
KNAPP ANDREW GANNETT
US15 patents
⚠️ This page may combine multiple inventors who share the name “KNAPP ANDREW GANNETT”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
CAMBRIDGE NEUROSCIENCE INC
13 patentsUS5686495ANov 11, 1997
Substituted hydrazinedicarboximidamides and methods of use thereof
CAMBRIDGE NEUROSCIENCE INC21 citations96
US5741661AApr 21, 1998
Substituted guanidines and derivatives thereof as modulators of neurotransmitter release and novel methodology for identifying neurotransmitter release blockers
CAMBRIDGE NEUROSCIENCE INC22 citations92
US5837737ANov 17, 1998
Hydrazinedicarboximidamide compounds and pharmaceutical composition comprising same
CAMBRIDGE NEUROSCIENCE INC15 citations82
US5672608ASep 30, 1997
Acenaphthyl substituted guanidines and methods of use thereof
CAMBRIDGE NEUROSCIENCE INC8 citations82
US5670519ASep 23, 1997
Acenaphthyl-substituted guanidines and methods of use thereof
CAMBRIDGE NEUROSCIENCE INC7 citations82
US5652269AJul 29, 1997
Substituted hydrazinecarboximidamides and methods of use thereof
CAMBRIDGE NEUROSCIENCE INC9 citations82
US6787569B1Sep 7, 2004
Therapeutic guanidines
CAMBRIDGE NEUROSCIENCE INC8 citations73
US5847006ADec 8, 1998
Therapeutic guanidines
CAMBRIDGE NEUROSCIENCE INC15 citations73
US5681861AOct 28, 1997
Aminoguanidines and methods of use of same
CAMBRIDGE NEUROSCIENCE INC6 citations73
US5677348AOct 14, 1997
Substituted aminoguanidines and methods of use thereof
CAMBRIDGE NEUROSCIENCE INC6 citations73
US6143791ANov 7, 2000
Therapeutic guanidines
CAMBRIDGE NEUROSCIENCE INC12 citations71
US6174924B1Jan 16, 2001
Therapeutic guanidines
CAMBRIDGE NEUROSCIENCE INC4 citations62
US6071969AJun 6, 2000
Substituted aminoguanidines and methods of use thereof
CAMBRIDGE NEUROSCIENCE INC1 citations62